Correlation Between Prime Medicine, and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Prime Medicine, and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prime Medicine, and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prime Medicine, Common and Caribou Biosciences, you can compare the effects of market volatilities on Prime Medicine, and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prime Medicine, with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prime Medicine, and Caribou Biosciences.
Diversification Opportunities for Prime Medicine, and Caribou Biosciences
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Prime and Caribou is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Prime Medicine, Common and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Prime Medicine, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prime Medicine, Common are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Prime Medicine, i.e., Prime Medicine, and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Prime Medicine, and Caribou Biosciences
Given the investment horizon of 90 days Prime Medicine, Common is expected to under-perform the Caribou Biosciences. But the etf apears to be less risky and, when comparing its historical volatility, Prime Medicine, Common is 1.08 times less risky than Caribou Biosciences. The etf trades about -0.09 of its potential returns per unit of risk. The Caribou Biosciences is currently generating about -0.03 of returns per unit of risk over similar time horizon. If you would invest 299.00 in Caribou Biosciences on August 24, 2024 and sell it today you would lose (101.00) from holding Caribou Biosciences or give up 33.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Prime Medicine, Common vs. Caribou Biosciences
Performance |
| Timeline |
| Prime Medicine, Common |
| Caribou Biosciences |
Prime Medicine, and Caribou Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Prime Medicine, and Caribou Biosciences
The main advantage of trading using opposite Prime Medicine, and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prime Medicine, position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.| Prime Medicine, vs. Terns Pharmaceuticals | Prime Medicine, vs. Acumen Pharmaceuticals | Prime Medicine, vs. Inozyme Pharma | Prime Medicine, vs. X4 Pharmaceuticals |
| Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |